Portfolio
2
companies
SatVu
SatVu provides high-resolution thermal imagery from space for defence and security intelligence.
Portal Biotech
Portal Biotech delivers single-molecule protein sequencing technology to transform proteomics and drug discovery.
Ana Bernardo-Gancedo
Senior Associate
The British Business Bank contributed £5m to the £30m financing alongside several new and existing backers.
"SatVu has created a unique technology at a time of great demand for defence innovation. They have proved the strategic value of their technology so we are pleased to provide the funding that will help them to scale and win further contracts."
The financing will be used to expand technical teams and accelerate the commercialisation of its proteomics platform.
"Portal Biotech’s technology offers unprecedented capabilities in protein identification and characterisation, providing unmatched detail on protein structure and modifications at the single-molecule level on accessible desktop instruments that bring this state-of-the-art characterisation to any lab. These powerful advances are essential for accelerating drug discovery and enhancing diagnostic precision, positioning Portal Biotech as the frontrunner in the race to unlock the full potential of protein sequencing."
-20webclip.png)